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CytotoxicityThe hexane, dichloromethane, ethyl acetate and aqueous fractions of an ethanolic extract of Centratherum
punctatum leaves were screened for antiplasmodial, HIV-1 reverse transcriptase inhibitory and cytotoxicity
properties. The crude extract exhibited both antiplasmodial (IC50 = 3.2 μg/ml) and HIV-1 reverse transcriptase
inhibitory (IC50=72.8 μg/ml) activities. A remarkable improvement in both antiplasmodial (IC50=0.419 μg/ml)
and HIV-1 reverse transcriptase inhibitory (IC50 = 52.4 μg/ml) activities was observed with dichloromethane
fraction. The study revealed the antiplasmodial and HIV-1 RT inhibitory effects of C. punctatum and its fractions,
especially the dichloromethane fraction. However, its safety index values [antiplasmodial (0.2), HIV-1 reverse
transcriptase inhibition (0.0017)] indicate that the fraction is cytotoxic.
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Despite all the efforts in combating malaria, it remains one of the
most threatening diseases in the developing world today. In 2010,
about 3.3 billion people were at risk of malaria, 81% of cases and 91%
of deaths occurred in Africa. Children under ﬁve years and pregnant
women were the most vulnerable (WHO, 2011). The widespread
resistance to commonly used antimalarial drugs has necessitated
the search for new antimalarial drugs. Plants have been a source of
antimalarial drugs or lead compounds for antimalarial drugs such as
quinine and artemisinin (Basco et al., 1994).
The involvement of enzymes in essential catalytic roles in many
physiological processes that may be altered during disease progression
makes them the most attractive targets for drug intervention in the
treatment of a number of human diseases (Copeland, 2005). One such
enzyme is HIV-1 reverse transcriptase (RT), a DNA dependent
polymerase that catalyses the synthesis of a double stranded DNA
copy from a single stranded HIV-RNA. The enzyme is for that reason,
essential for the life cycle of HIV-1 and hence a target for anti-HIV
therapy (Spallarossa et al., 2009). Apart from synthetic drugs, several
plant species and herbal products have been screened for inhibitory
effects towards the enzyme (Bessong et al., 2005; Ndhlala et al.,
2010). The beneﬁcial effects of herbs and herbal remedies could bey Elsevier B.V. All rights reserved.due to direct inhibition of HIV replication by blocking RT, boosting of
the immune system or curative effects on the opportunistic infections.
Centratherum punctatum Cass. (Asteraceae), commonly known as the
Brazilian bachelor Button, is a scented bushyperennial plant. It has awell
branched stem with refreshing pineapple-scented foliage and purple
ﬂower heads (Gbolade et al., 2009). In Brazil, it is used as a relaxative
and for the treatment of heart problems (Costa Bieski et al., 2012). The
leaves possess antimicrobial, antioxidant and antiproliferative properties
(Pawar and Arumugam, 2011). Fifty nine compounds were identiﬁed in
the leaf oil of C. punctatum, of which sesquiterpenes were the major
compounds (Gbolade et al., 2009). Centratherin, a sesquiterpene lactone
and its derivative isocentratherin have been reported for C. punctatum
(Ohno et al., 1979; Bevelle et al., 1981).
In the present study we report the antiplasmodial, HIV-1 reverse
transcriptase (RT) inhibition and cytotoxicity properties of C. punctatum
growing in South Africa.2. Materials and methods
2.1. Plant collection
Leaves of C. punctatum were collected in June, 2013 from the
Botanical Garden of the University of KwaZulu-Natal, Pietermaritzburg,
South Africa. After identiﬁcation by the Curator, a voucher specimen
(Chukwujekwu #7 NU) was deposited in the Herbarium of University
of KwaZulu-Natal, Pietermaritzburg. Plant material was dried at 50 °C
Table 1
In vitro antiplasmodial activity and cytotoxicity of Centratherum punctatum and its
fractions against chloroquine-sensitive (CQS) strain of P. falciparum (NF54) and Chinese
Hamster Ovarian (CHO) cell line.
Sample NF54: IC50 (μg/ml) CHO: IC50 (μg/ml) SI
Crude extract 3.2± 2.4 2.0± 0.21 0.6
Hexane fraction 7.1± 0.88 7.7± 1.86 1.1
Dichloromethane fraction 0.419±0.06 0.089±0.01 0.2
Ethyl acetate fraction 4.9± 1.7 2.4± 0.22 0.5
Aqueous fraction N100±ND
CQ 5.8± 0.4 ng/ml
Artesunate 4.1 ng/ml
Emetine 0.035±0.02
Selectivity index (SI)= IC50 CHO/IC50 NF54; ND=not determined.
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temperature prior to extraction.
2.2. Extraction and fractionation
The oven-dried leaves (19.6 g) were extracted with 80% ethanol
(300 ml) with sonication for 1 h and then left overnight with stirring
to extract. The extract was ﬁltered through a Büchner funnel using
Whatman no. 1 ﬁlter paper. The extraction and ﬁltration were
subsequently repeated three times with 300 ml 80% ethanol, and the
combined solvent evaporated under reduced pressure at 30 °C. Liquid–
liquid partitioning was done by dissolving the crude extracts (3.2 g) in
aqueous methanol (300ml, 80% v/v) followed by sequential extraction
with hexane, dichloromethane and ethyl acetate as described in
Chukwujekwu et al. (2013). All four fractions were used in subsequent
assays.
2.3. Antiplasmodial assay
The test samples were tested in triplicate on each occasion against
chloroquine-sensitive (CQS) strain of Plasmodium falciparum (NF54).
Continuous in vitro cultures of asexual erythrocyte stages of P. falciparum
were maintained using a modiﬁed method of Trager and Jensen (1976).
Quantitative assessment of antiplasmodial activity in vitro was
determined via the parasite lactate dehydrogenase assay using amodiﬁed
method described by Makler et al. (1993). The test samples were
prepared to a 20mg/ml stock solution in 100% DMSO and sonicated to
enhance solubility. Stock solutions were stored at −20 °C. Further
dilutions were prepared on the day of the experiment. Chloroquine
diphosphate (CQ) (Sigma) and artesunate (Sigma) were used as the
reference drugs. A full dose–response was performed for all compounds
to determine the concentration inhibiting 50% of parasite growth (IC50-
value). Test samples were tested at a starting concentration of
100 μg/ml, which was then serially diluted 2-fold in complete medium
to give 10 concentrations; with the lowest concentration being
0.2 μg/ml. The same dilution technique was used for all samples. CQ and
artesunate were tested at a starting concentration of 1000 ng/ml. The
highest concentration of solvent to which the parasites were exposed to
had no measurable effect on the parasite viability (data not shown). The
IC50-values were obtained using a non-linear dose–response curve ﬁtting
analysis via GraphPad Prism v.4.0 software.
2.4. HIV-1 reverse transcriptase (RT) inhibitory bioassay
The inhibitory effect of leaf extracts of C. punctatum and its fractions
on reverse transcription was evaluated using a non-radioactive HIV-RT
colourimetric enzyme-linked-immunosorbent serologic assay (ELISA)
kit obtained from Roche Diagnostics, Germany. The assay procedure
followed a protocol supplied together with the kit, under nuclease-
free conditions. The details of the assay are outlined in Ndhlala et al.
(2010). Three tubes containing water instead of sample were used as
negative controls. Another set of three tubes containing lysis buffer
and no HIV-1-RT added were included. Combivir® (GlaxoSmithKline)
[lamivudine (1.0 mg/ml) + zidovudine (2.0 mg/ml)] and Kaletra®
(Abbott) [lopinavir (8.9mg/ml)+ ritonavir (2.2mg/ml)] were used as
positive controls. Results were presented as means ± standard errors
of two independent experiments; each experiment was done in
duplicate. The IC50 (inhibition concentration) values of the test samples
were calculated using GraphPad Prism (version 4.0) statistical software
programme for Windows (GraphPad Software Inc.).
2.5. Cytotoxicity assay
Sampleswere tested for in vitro cytotoxicity against amammalian cell-
line, Chinese Hamster Ovarian (CHO) using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazoliumbromide (MTT)-assay. TheMTT-assay is usedas a colourimetric assay for cellular growth and survival, and compares
well with other available assays (Mosmann, 1983; Rubinstein et al.,
1990). The tetrazolium salt MTT was used to measure all growth and
chemosensitivity. Samples were tested in triplicate on one occasion.
The same stock solutions were used as for antiplasmodial
testing. Dilutions were prepared on the day of the experiment.
Emetine hydrochloride (Sigma) was used as the reference drug in all
experiments. The initial concentration of emetine was 100 μg/ml,
which was serially diluted in complete medium with 10-fold dilutions
to give 6 concentrations, the lowest being 0.001μg/ml. The same dilution
technique was applied to all test samples. The highest concentration of
solvent to which the cells were exposed to had no measurable effect
on the cell viability (data not shown). The 50% inhibitory concentration
(IC50) values were obtained from full dose–response curves, using a
non-linear dose–response curve ﬁtting analysis via GraphPad Prism v.4
software.
3. Results and discussion
The results of the antiplasmodial activity, cytotoxicity and safety index
of C. punctatum crude extract and its fractions are presented in Table 1.
With exception of the aqueous fraction, the crude extract and its fractions
exhibited remarkable antiplasmodial activity. In comparison with the
crude extract (IC50 = 3.2 μg/ml), there is a signiﬁcant improvement in
the antiplasmodial activity of the dichloromethane fraction (IC50 =
0.419 μg/ml). The other fractions retained some antiplasmodial activity
but not as active as the crude extracts. The cytotoxicity results of the
crude extract and its fractions revealed that these samples are cytotoxic.
The same pattern observed in the antiplasmodial activity of the samples
was repeated. The dichloromethane fraction that displayed the most
promising antiplasmodial activity was the most cytotoxic. Sakamoto
et al. (2005) observed that sequential partition of ethanolic extract from
Eremanthus species with solvents of increasing polarity allows the
achievement of a sesquiterpene enriched dichloromethane fraction. It
shows that whatever compound(s) responsible for the cytotoxicity
activity observed could be responsible for the antiplasmodial activity
displayed by the samples. The dichloromethane fraction being the most
active, possibly due to the high concentration of sesquiterpenes it
contains. The low values of safety index (SI) (Table 1) suggest that the
antiplasmodial activity is likely linked to a general cytotoxic effect.
The HIV-1 RT inhibitory activity of the crude leaf extract of
C. punctatum and its fractions are presented in Table 2. Four levels of
activity are deﬁned in this assay with activity below 25% being
considered insigniﬁcant, 25–50% low, 50–75% moderate and 75–100%
high. At the highest concentration (250 μg/ml), the crude extract and
the fractions exhibited high activity against RT. A trend similar to the
antiplasmodial activity was observed, with the dichloromethane
fraction showing the best activity (IC50 value of 52.4 μg/ml). However,
the SI value (0.0017) of the dichloromethane fraction is very low. This
also suggests that the activity might be likely due to the cytotoxicity of
the fraction.
Table 2
Dose dependent HIV-1 RT inhibitory effects of Centratherum punctatum and its fractions.
Sample Concentration (μg/ml) IC50 (μg/ml)
31.2 62.5 125.0 250.0
Crude extract 33.0± 1.0 43.4± 2.4 59.1± 1.9 86.6± 2.3 72.8± 1.3
Dichloromethane fraction 30.6± 1.6 61.4± 0.4 66.4± 1.3 88.9± 1.1 52.4± 0.2
Ethyl acetate fraction 24.8± 1.8 49.8± 3.6 65.4± 2.8 75.0± 0.9 70.6± 2.1
Positive controls Concentration (μg/ml) IC50 (μg/ml)
9.4 18.8 37.5 75.0
Lamivudine 8.2± 0.2 26.6± 0.1 41.3± 0.3 76.4± 2.2 40.9± 0.2
Lopinavir 13.5± 1.1 31.3± 0.9 52.4± 0.8 78.4± 1.3 34.3± 0.3
Ritonavir 10.7± 0.3 37.8± 1.2 53.2± 1.3 66.2± 0.9 36.7± 0.1
Zidovudine 16.1± 0.3 39.2± 0.7 61.2± 1.9 92.1± 07 25.5± 0.1
19J.C. Chukwujekwu et al. / South African Journal of Botany 90 (2014) 17–19Anumber of germacranolide sesquiterpene lactones, centratherin and
its derivative isocentratherin have been isolated from C. punctatum (Ohno
et al., 1979; Bevelle et al., 1981; Amaya et al., 2012). The cytotoxicity and
genotoxicity effects of these compounds have been reported. Previous
studies described antiproliferative effects of centratherin isolated from
Camchaya calcarea against lung cancer cells (NCI-H187) (Vongvanich
et al., 2006), and glioblastoma cells (U87-MG and U251) (Lobo et al.,
2012), trypanocidal activity of both centratherin and isocentratherin
isolated from Hololepis pedunculata (Almeida et al., 2006), genotoxic
effects of centratherin on human lymphocytes (Burim et al., 2001).
4. Conclusions
The study revealed the antiplasmodial and HIV-1 RT inhibitory effects
of C. punctatum and its fractions, especially the dichloromethane fraction.
However, the study also revealed the cytotoxicity of this fraction. To the
best of our knowledge, this is the ﬁrst report of antiplasmodial and HIV-
1 RT inhibitory activities of C. punctatum and its fractions. We are
currently working on isolating the active principle(s) from the
dichloromethane fraction. The isolation and characterisation of the active
principle(s) will hopefully conﬁrmwhich compounds are responsible for
the biological activity observed. If the active principle(s) still retain the
biological activity observed, then a structure–activity study will be
recommended with the aim of reducing the toxicity and retaining the
antiplasmodial and HIV-1 RT inhibitory activities.
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